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The development paths of interventional medical devices are long and involve a significant numbers of iterative design steps. 
Composite interventional catheters deliver implants, facilitate the deployment of delicate therapeutic instruments, measure 
pressures and temperatures and can remove clots and foreign bodies. This paper summarizes the history of composite 
interventional catheters and the key evolutions in terms of materials and reinforcement structures. The current design practices, 
performance standards and general guidance available to assist composite interventional catheter design are reviewed. The 
environmental factors that affect the companies in which many of the leading edge interventional composite catheter designs are 
developed are also examined. A Predictive Modelling Framework is proposed to guide the design of composite interventional 
catheters to meet the key user needs. Two distinct but compatible methodologies are selected: The first method involves use of a 
DOE (Design of Experiments) approach to understand the influence of key variables on final catheter properties; The second 
involves the creation of customizable Finite Element models of the various potential catheter structures. The results of the 
predictive model constructed based on the DOE approach for braided composite catheters are presented and compared with 
experimental data. The DOE shows good alignment with experimental data in most cases. The sources of noise and error in the 
initial model are examined and potential improvements and learnings are discussed, with special focus on the results with poorer 
alignment. 
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1.0 Background: 
In 1929 Werner Forssmann passed a lubricated ureteral catheter into his heart using a venous puncture of his left 
arm and is recognised as the first person to document human right heart catheterization.[1] Andre Cournard; 
working with Dickenson Richards of Columbia University began to systematically catheterise the right side of the 
heart in early 1940’s.[2] The catheters they used were composed of an inner framework of fabric covered with 
polyvinyl chloride with comminuted tin added for radiopacity.[3] These catheters are recognised as the first 
composite interventional catheters used in clinical practice.  Cournard, Richards and Forssmann were awarded the 
Nobel Prize for Medicine in 1956 for their collective contributions to cardiac catherisation.[4] 
  
Fig 1. Pebax based braid and coil reinforced interventional 
composite catheters 5-10Fr range (1.7-3.3mm outer diameter). [5] 
Fig 2.  Human vascular system; navigated by composite 
catheter based interventional devices. 
A patent was granted to Robert Stevens and Cordis Corporation in December 1969 for a braided catheter using steel 
wire.[6] This design exhibited excellent torqueability, high burst pressure and provided radiopacity through the use 
of bismuth subcarbonate milled into the polyurethane prior to extrusion. The tip section contained no wire which 
improved shape retention and softness[7]. Patents for coil reinforced sheath technology for vascular access began to 
appear in mid-1980’s.[8] Today the majority of composite interventional catheters feature either braid, coil or a 
combination as the reinforcing layer. Improvements in catheter design, materials and fabrication techniques have 
both facilitated and enabled new therapies in the neurovascular,[9] endovascular,[10] and cardiovascular[11] 
interventional areas.  
2.0 The current challenges of Interventional composite catheter design 
Interventional catheters use the vascular system (see Fig. 2) to access a particular location for a diagnostic or 
therapeutic treatment. Performance requirements for composite interventional catheters used in different therapeutic 
areas are similar. However, the literature around catheter-based devices is written from a disease state or clinical 
viewpoint so this commonality in terms of catheter technology cannot be effectively examined by literature review. 
This lack of a meaningful body of knowledge, partially explains the tendency towards iteration based design that 
predominates in the development of catheter based devices. The current fragmented strategies by individual 
companies have been identified as unsustainable and a cause of increasing costs and timelines from bench to bedside 
for new medical devices.[12]  
A second factor relates to the limited availability of standards. The area of intravascular catheter design has a single 
ISO standard (ISO 10555-1-6:2013) in terms of guidance for standard functional requirements.[13] This standard 
provides guidance on tensile strength testing for reinforced vascular catheters. Flexural modulus (ISO178:2010) and 
flow rate (ISO11070-1-2013) can both be tested against other recognized standards, but other characteristics such as 
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torquability, torsional response, kink and pushability have no guidance in terms of ISO standards. The FDA have 
provided guidance specific to intravascular stents and their delivery systems.[14] This guidance is mainly in relation 
to balloon based systems but the flexibility, kink resistance, torque and catheter bond strength guidance can be 
applied to interventional composite catheter development. This lack of standard test methods compounds the issue 
with codification of catheter design knowledge. 
A third point is that much of the early stage R&D in medical devices is dominated by individuals, usually in 
academic or clinical settings who are involved in the development of new technology in their respective fields. [15-
17] These user innovators have been shown to produce inventions that have higher technical importance and greater 
impact than corporate inventions in the same area.[18] Larger, more established firms play an important part later in 
the development process (often through acquisition of the start-up companies).[16] It could be argued that many 
major medical device companies are effectively outsourcing much of their early stage R&D to start-up 
companies.[19] [20]  
For smaller start-up companies particularly clinically focused ones, a vibrant ecosystem is required to support their 
needs.[21, 22] Often with catheter-based devices, the start-up’s technical expertise is focused on their core 
differentiated technology (an implant or a unique technology in terms of the therapy or treatment delivered). These 
companies need to partner with specialist medtech suppliers to develop the catheter based delivery system.[23] The 
fragmented nature of these relationships means no strong body of knowledge on interventional composite catheter 
design has evolved within the medical device industry. 
Due to the nature of device regulation, companies seek to have a high level of confidence that the device design 
concept is largely proven before entering formal design control. Much of the crucial design work happens before the 
design cycle formally begins (from a regulatory viewpoint). This results is a situation where a lot of concepts are 
effectively developed, refined and proven at a “Phase 0” or “Pre-Design Stage”. Generally, limited or relatively 
minor changes occur once the selected concept proceeds to formal design control. 
Computer simulation and modelling; finite element analysis (FEA) and computational fluid dynamics (CFD) in the 
area of vascular devices has been examined by Morrison.[24] FEA [25-28] has been described widely as a practice 
usually in relation to metal-based components. Zhang[25] is one of the few who has applied it to composite catheter 
design. Design of experiments (DOE) [29-31] has been employed as an early stage design tool and aid to predictive 
modelling within the medical device design space. In 2016 the FDA issued guidance on the reporting of 
computational modelling studies for medical device design.[32] Guidance from the FDA on the verification and 
validation in computational modelling of medical devices is expected imminently.[33] This is expected to elevate 
computational testing to equal consideration, which bench, animal, and human testing currently receive. 
3.0 Predictive Modelling Framework: 
This paper describes the development of a predictive modelling methodology for early stage catheter design as an 
alternative to iteration based design. This tool will allow a set of user needs to be translated into an optimal 
theoretical design using fixed geometric constraints. This will reduce the number of design iterations and therefore 
reduce the cost and time of reaching an acceptable concept design. 
Fig 3 shows the information flows and conceptual blocks of the Predictive Modelling Framework.  It consists of two 
discreet feedback loops. The lower loop is focused on determining the catheter performance requirements (i.e. 
Tensile Modulus, Bend Stiffness etc.). The upper loop will take these catheter performance requirements and the 
geometric constraints and translate them into a set of catheter design inputs (i.e. Outer material durometer, braid 
wire size etc.). The catheter could then be built to this specification. Testing data could then be added to the model.  
4 Author name / Procedia Manufacturing  00 (2019) 000–000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.  Information flow and discreet steps of proposed Predictive Model Framework. 
4.0 Methods  
This paper explores how well a preliminary predictive modelling approach based on classical design of experiments 
(DOE) compared to a baseline created by building and testing actual composite catheters. A second predictive 
modelling approach using finite element analysis (FEA) has been started and will be the subject of future work. 
Both the DOE and the FEA approach are being trialled based on their potential to become complementary 
components of a predictive modelling methodology for interventional composite catheter design. 
4.1 Methods; design of experiments 
JMP® Pro Version 11 software from SAS was used to design the DOE and analyse the test data. Five factors were 
chosen for the initial DOE to examine the braided composite catheters. These factors are shown in Table 1. The 
inner diameter of all catheter shafts examined was 2.30mm. A half-fractional design with 15 degrees of freedom was 
chosen. This allowed main effects and 2 way interactions to be examined. The liner material (PTFE), braid wire 
profile (flat), braid wire material of construction (304 stainless Steel) and outer material type Pebax® range 
(polyether-block-amide thermoplastic elastomer) were kept consistent across the initial DOE. Thin walled PTFE 
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lined interventional composite catheters are the area of most commercial interest. The bulk of these types of 
catheters feature these 4 design characteristics.   
Table 1  Factors selected for the initial half factorial DOE. 
Factor Description 
Outer material 
Durometer 
Grades between 74D and 25D are available within the Pebax® range. The higher the number the higher the durometer 
therefore the stiffer the material. 
Wall Thickness Key design characteristic for interventional composite catheters. Companies are generally trying to minimise it. 
Braid Pattern Standard & diamond patterns are used in braided catheter design. Both have same number of wire starts. 
Braid Angle 
The braid angle is the angle formed between a longitudinal axis (parallel to the tubing axis, which bisects the angle where 
the wires cross in the braid pattern) and the angle formed by the braid wire. As braid angle increases number of wire 
crossings per unit length reduces. Number of crossings per inch (PPI) is the control variable for angle in catheter braiding.  In 
Table 2 Braid angle is being expressed as PPI. 
Braid cross 
sectional area 
(CSA) 
Different wire sizes and profiles can be used in braided catheter assembly. Often thin walled designs are attempting to 
maximise the braided materials cross sectional area for a specified wall thickness. This leads to use high aspect ratio 
rectangular cross section reinforcement shapes rather than round reinforcement shapes. In Table 2 below the CSA of 6452, 
968 and 3226 microns were achieved with rectangular profiles of .051mm*.127mm,  .013mm*.076mm and  
.025mm*.127mm respectively. 
 
After completion of the screening DOE it was decided to add two centre point runs for the standard and the diamond 
braid configuration. This was done to improve the ability of the model to reflect the reality of the process. The DOE 
experimental design (including the midpoint runs) is shown in Table 2. The parts manufactured were tested using 7 
validated test methods.   The 7 test methods are listed in the first column of Table 3. Three data points were taken 
per run for each test. 
Table 2  Braided Composite DOE Experimental Design. 
Run 
No 
Outer 
layer  
Wall 
(mm) 
PPI Wire CSA 
(m2) 
Braid 
Pattern 
Run 
No 
Outer 
Layer 
 
Wall 
(mm) 
PPI Wire CSA 
(m2) 
Braid 
Pattern 
1 74D Pebax .279 12 6452 Diamond 10 74D Pebax .178 53 6452 Diamond 
2 25D Pebax .178 12 968 Standard 11 25D Pebax .178 53 968 Diamond 
3 25D Pebax .178 53 6452 Standard 12 25D Pebax .279 12 6452 Standard 
4 74D Pebax .279 53 968 Diamond 13 74D Pebax .178 53 968 Standard 
5 74D Pebax .279 12 968 Standard 14 25D Pebax .178 12 6452 Diamond 
6 25D Pebax .279 12 968 Diamond 15 74D Pebax .178 12 968 Diamond 
7 74D Pebax .279 53 6452 Standard 16 25D Pebax .279 53 968 Standard 
8 74D Pebax .178 12 6452 Standard 17 55D Pebax .229 26 3226 Standard 
9 25D Pebax .279 53 6452 Diamond 18 55D Pebax .229 26 3226 Diamond 
 
5.0 Results: 
The current predictive model is based on a half factorial DOE with midpoints, which ranged the five key 
interventional catheter design parameters described in Table 1. JMP® Pro software was used to fit a model for the 
data generated for each of the characteristics listed in Tables 3. The Prediction Profiler function was then used to 
create an adjustable model that could be configured to represent Baseline A and Baseline B. These configured 
6 Author name / Procedia Manufacturing  00 (2019) 000–000 
versions of the profiler are shown as Fig 4 and 5 respectively. The results for both Baseline A and B are shown in 
Table 3. 
 
Fig 4. Prediction Profiler configured for Baseline A. Results for each of the 7 criteria shown along left hand side. 
Table 3   Results for Baseline A and Baseline B design actual value versus predicted value. 
 Baseline A Baseline B 
Test Method Actual Value Predicted Value 
(Percentage error) 
Actual Value Predicted Value 
(Percentage error) 
Tensile Modulus (MPa) 337.5 376.7 (12%) 363 404.5 (11%) 
Kink Diameter (mm) 40.72 54.6 (34%) 33.27 29.4 (-12%) 
Column Strength (N/mm²) 370.67 290.1 (-22%) 595.7 654.3 (10%) 
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Pattern 
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No 
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9 25D Pebax .279 53 6452 Diamond 18 55D Pebax .229 26 3226 Diamond 
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Fig 5. Prediction Profiler configured for Baseline B. Results for each of the 7 criteria shown along left hand side. 
6.0 Discussion of Results: 
At the concept stage of a composite catheter design, a design tool with the ability to predict a critical performance 
characteristic to an accuracy of +/- 20% would be of real value. This +/-20% is a practical yardstick based on AIAG 
guidance for measurement system analysis.[34] Review of Table 3 shows that good alignment was achieved in 
terms of Tensile Modulus, Bend stiffness and Torsion results. All the predicted values were within +/-12% of the 
tested values for both Baseline trials. Column Strength (worst case 22% variance) and Crush Resistance (worst-case 
26% variance) exhibited poorer agreement. Flex Modulus (worst case 32% variance) and Kink Diameter (worst-case 
34% variance) exhibited the widest range in terms of results. 
The adjusted R2 values for all five models are presented in Table 4. These are all relatively high indicating that the 
model fits the data relatively well. In the case of Column Strength, Crush resistance, Bend Stiffness and Torsion 
these values are close. A wider range exists with Tensile Modulus, Kink Diameter and Flex Modulus.  The initial 
8 Author name / Procedia Manufacturing  00 (2019) 000–000 
results demonstrate that DOE shows considerable potential as a technique for predictive modelling of interventional 
composite catheter performance. Reducing the sources of known error and implementing the learnings from this 
initial effort in future work with both braid and coil reinforced composite catheter is expected to result in better 
models with  high prediction accuracy. 
Table 4 R2 and Adjusted R2 Values for the data from each of the 7 tests used to construct the predictive model. 
Test Method R2 Value Adjusted R2 Value Test Method R2 Value Adjusted R2 Value 
Tensile Modulus .919 .884 Bend Stiffness .990 .986 
Kink Diameter .950 .928 Flex Modulus .911 .870 
Column Strength .987 .982 Torsion .980 .971 
Crush Resistance .998 .997    
 
6.1 Sources of Error and learnings 
A number of sources of error were identified during the catheter build and test steps. The durometer range was too 
wide. Assembling catheters in low durometer soft materials (2533 Pebax) is difficult. With thin walls and low 
profile reinforcing braid wire the soft material effect is magnified. The final manufacturing step of de-coring the low 
durometer catheters without stretching became difficult. In future work a higher durometer 3533 or 4033 Pebax will 
form the lower limit. Composite interventional catheter shafts are extremely rarely manufactured from very low 
durometer materials because of the pushability requirements need to track a catheter to its treatment location.  
Spring braid wire was used for the smaller cross sectional area braid wires (968 and 3,226 m2) while the largest 
size (6,452 m2) was of the annealed form. Spring braid wire has a tensile strength of 2,250 MPa. Annealed braid 
wire has a tensile strength of 820 MPa. In future build spring type braid wire will be used for all builds. Finally the 
braided catheters featuring low PPI (12 PPI corresponding to an angle of 66° at the experimental catheter size) had 
issues with early failure on some tests when combined with other extreme conditions (thin wall and low durometer). 
In future work the lower limit will be specified with a slightly higher minimum limit (15 PPI corresponding to an 
angle of 61° at the experimental catheter size). Again, this change will not limit the utility of the model as catheters 
are generally designed with angles below 45° to optimize torque transfer characteristics. 
7.0 Conclusion: 
This pilot DOE approach demonstrates considerable potential as a basis for a predictive model methodology for 
composite interventional catheter design. The approach will need refinement in terms of test methods and to 
minimise the noise from catheter manufacturing techniques. It will also need to be applied to coiled constructs and 
applied over a broader range of catheter sizes. However the initial work demonstrates the practical viability of using 
a DOE generated predictive model as a tool to practically apply the conceptual predictive modelling framework 
outlined in Fig 3. 
It is planned to run a subsequent DOE on braided composite catheters after implementing the learnings described in 
section 6.1. It is also planned to complete a DOE on coil reinforced composite catheters to further expand the range 
of the predictive model. Finally the FEA approach will be trialled and compared with the DOE results to date to 
assess its suitability as a component of a future integrated predictive modelling methodology for interventional 
composite catheter design. 
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